TD Waterhouse Canada’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-360
Closed -$540 1726
2023
Q3
$540 Hold
360
﹤0.01% 1588
2023
Q2
$702 Hold
360
﹤0.01% 1630
2023
Q1
$720 Hold
360
﹤0.01% 1622
2022
Q4
$806 Hold
360
﹤0.01% 1578
2022
Q3
$832 Hold
360
﹤0.01% 1593
2022
Q2
$954 Hold
360
﹤0.01% 1625
2022
Q1
$1.74K Hold
360
﹤0.01% 1615
2021
Q4
$2.98K Buy
+360
New +$3.54K ﹤0.01% 1527

Other funds holding CLLS

TD Waterhouse Canada's CLLS Position: Q4 2023 in Review

TD Waterhouse Canada sold out of Cellectis (CLLS) in Q4 2023, closing a stake of 360 shares — an estimated $540 sold.

TD Waterhouse Canada first reported a position in CLLS in Q4 2021 and held it in 8 quarters. The position peaked at $2.98K in Q4 2021. 34 funds tracked by Wall St. Rank hold CLLS as of Q4 2023.

  • TD Waterhouse Canada reported no remaining Cellectis position as of Q4 2023 after selling out during the quarter.
  • TD Waterhouse Canada sold 360 Cellectis shares in Q4 2023, an estimated $540.
  • TD Waterhouse Canada first reported a position in Cellectis in Q4 2021 and held it in 8 quarters.
  • TD Waterhouse Canada's Cellectis position peaked at $2.98K in Q4 2021.
  • 34 funds tracked by Wall St. Rank held Cellectis as of Q4 2023.

Based on TD Waterhouse Canada's 13F filing for Q4 2023, filed 12 Feb 2024.